Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Nicole A. Schreiber"'
Autor:
Karen A. Autio, Emmanuel S. Antonarakis, Tina M. Mayer, Daniel H. Shevrin, Mark N. Stein, Ulka N. Vaishampayan, Michael J. Morris, Susan F. Slovin, Elisabeth I. Heath, Scott T. Tagawa, Dana E. Rathkopf, Matthew I. Milowsky, Michael R. Harrison, Tomasz M. Beer, Arjun V. Balar, Andrew J. Armstrong, Daniel J. George, Channing J. Paller, Arlyn Apollo, Daniel C. Danila, Julie N. Graff, Luke Nordquist, Erica S. Dayan Cohn, Kin Tse, Nicole A. Schreiber, Glenn Heller, Howard I. Scher
Publikováno v:
European Urology Open Science, Vol 34, Iss , Pp 70-78 (2021)
Background: Phase 2 trial endpoints that can be utilized in high-risk biochemical recurrence (BCR) after prostatectomy as a way of more rapidly identifying treatments for phase 3 trials are urgently needed. The efficacy of abiraterone acetate plus pr
Externí odkaz:
https://doaj.org/article/7cb29db5a1d04ef391276d51f770d34a
Autor:
Howard I. Scher, Ryan Dittamore, Dena Marrinucci, Scott T. Tagawa, David M. Nanus, Nicole A. Schreiber, Ryon P. Graf, Rachel Krupa, Jessica Louw, Myriam Kossai, Juan Miguel Mosquera, Mark Landers, Adam Jendrisak, Himisha Beltran
Figure S1: Examples of a decision boundary that separate class A (red) from class B (blue) in 1 dimension (figure 1A) and 2 dimensions (figure 1B); Figure S2: Schematic of the supervised learning process (A) and leave one out cross validation (B); Fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec9b853ef189603226c86b6b11fd33d9
https://doi.org/10.1158/1078-0432.22459598.v1
https://doi.org/10.1158/1078-0432.22459598.v1
Autor:
Ryan Dittamore, Glenn Heller, Mark Landers, Martin Fleisher, Hebert A. Vargas, Lyndsey Dugan, Jessica E. Louw, Pascal Bamford, David Lu, Rachel Krupa, Stephanie Greene, Jerry Lee, Yipeng Wang, Adam Jendrisak, Brigit McLaughlin, Nicole A. Schreiber, Ryon P. Graf, Howard I. Scher
The heterogeneity of an individual patient's tumor has been linked to treatment resistance, but quantitative biomarkers to rapidly and reproducibly evaluate heterogeneity in a clinical setting are currently lacking. Using established tools available
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c402becdf1a2391aa635f0698de7c41
https://doi.org/10.1158/0008-5472.c.6509265.v1
https://doi.org/10.1158/0008-5472.c.6509265.v1
Autor:
Howard I. Scher, Ryan Dittamore, Dena Marrinucci, Scott T. Tagawa, David M. Nanus, Nicole A. Schreiber, Ryon P. Graf, Rachel Krupa, Jessica Louw, Myriam Kossai, Juan Miguel Mosquera, Mark Landers, Adam Jendrisak, Himisha Beltran
Purpose: The transition of prostate adenocarcinoma to a predominantly androgen receptor (AR) signaling independent phenotype can occur in the later stages of the disease and is associated with low AR expression +/− the development of small-cell or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6437742746c507d642175adc86f3c0f9
https://doi.org/10.1158/1078-0432.c.6524261.v1
https://doi.org/10.1158/1078-0432.c.6524261.v1
Autor:
Daniel C. Danila, Karen A. Autio, Daniel J. George, Daniel H. Shevrin, Kin Tse, Tina M. Mayer, Susan F. Slovin, Michael R. Harrison, Michael J. Morris, Arjun Vasant Balar, Arlyn Apollo, Scott T. Tagawa, Tomasz M. Beer, Nicole A. Schreiber, Luke T. Nordquist, Mark N. Stein, Elisabeth I. Heath, Dana E. Rathkopf, Julie N. Graff, Ulka N. Vaishampayan, Channing J. Paller, Erica S. Dayan Cohn, Howard I. Scher, Andrew J. Armstrong, Emmanuel S. Antonarakis, Matthew I. Milowsky, Glenn Heller
Publikováno v:
European Urology Open Science
European Urology Open Science, Vol 34, Iss, Pp 70-78 (2021)
European Urology Open Science, Vol 34, Iss, Pp 70-78 (2021)
Background: Phase 2 trial endpoints that can be utilized in high-risk biochemical recurrence (BCR) after prostatectomy as a way of more rapidly identifying treatments for phase 3 trials are urgently needed. The efficacy of abiraterone acetate plus pr
Autor:
Joseph D. Schonhoft, Nicole A. Schreiber, Ethan Barnett, Melissa Harvey, Audrey Gill, Howard I. Scher, Ryon P. Graf, David S.K. Lu, Rachel Krupa, Sarah Orr, Adam Jendrisak, Emily Carbone
Publikováno v:
Journal of Circulating Biomarkers, Vol 9, Iss 1, Pp 13-19 (2020)
Journal of Circulating Biomarkers
Journal of Circulating Biomarkers
Introduction: Here we describe the development of a protein immunofluorescent assay for the detection of nuclear-localized androgen receptor variant 7 (AR-V7) protein within circulating tumor cells (CTCs) identified in patient blood samples. Used in
Autor:
Konrad H. Stopsack, Irenaeus C. Chan, Evelyn Schmidt, Alex Panchot, Samantha McNulty, Nicole A. Schreiber, Yiwen Zhang, Kathryn L. Penney, Michael F. Berger, Luis A. Diaz, Ross L. Levine, Kelly L. Bolton, Lorelei A. Mucci, Philip W. Kantoff
Publikováno v:
Cancer Prevention Research. 16:P011-P011
Background: Clonal hematopoiesis (CH), the presence of acquired mutations in leukemia driver genes, promotes systemic inflammation and is common among aging men. Prostate cancer, a subset of which is lethal, also develops in aging men. We hypothesize
Publikováno v:
Animal Reproduction Science. 244:107048
Thrombospondin-1 (THBS1) is involved in the process of angiogenesis and is down-regulated by insulin-like growth factor 1 (IGF1) in porcine granulosa cells (GC), but what other hormones regulate GC THBS1 and its role in follicular growth is unclear.
Autor:
J.N. Gilliam, Nicole B. Schreiber, J.R. Evans, Leon J. Spicer, J. A. Williams, Luis F. Schutz, M.L. Totty
Publikováno v:
Domestic Animal Endocrinology. 59:90-99
Abundance of G protein-coupled receptor 34 (GPR34) mRNA is greater in granulosa cells (GC) of cystic vs. normal follicles of cattle. The present experiments were designed to determine if GPR34 mRNA in GC changes during selection and growth of dominan
Publikováno v:
Animal, Vol 11, Iss 5, Pp 811-819 (2017)
Angiogenin is a member of the ribonuclease A superfamily of proteins that has been implicated in stimulating angiogenesis but whether angiogenin can directly affect ovarian granulosa or theca cell function is unknown. Therefore, the objective of thes